Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-181609
Filing Date
2022-06-24
Accepted
2022-06-24 16:54:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d342906dsc13da.htm SC 13D/A 28616
  Complete submission text file 0001193125-22-181609.txt   30082
Mailing Address 7 LUCENT DRIVE LEBANON NH 03766
Business Address 7 LUCENT DRIVE LEBANON NH 03766 603-643-7110
Adimab, LLC (Filed by) CIK: 0001545672 (see all company filings)

EIN.: 800669559 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Adagio Therapeutics, Inc. (Subject) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92804 | Film No.: 221040769
SIC: 2836 Biological Products, (No Diagnostic Substances)